22 to 23 June 2015

NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester

Please note that this agenda is subject to change prior to the meeting.

Final Agenda – Monday 22 June 2015

The meeting will start promptly at 10.00 and is expected to finish at approximately 16.15

  1. Welcome and introductions - Part 1 only (open session)
  2. Code of Conduct for members of the public attending the meeting - Part 1 only (open session)
  3. Objectives of the morning and Declarations of Interest. - Part 1 only (open session)
  4. Topic: Headaches update
    1. Review and discussion of the health economic evidence - Part 1 only (open session)
      1. Review question: In people with chronic or episodic migraine (with or without aura), what is the clinical evidence and cost-effectiveness of prophylactic pharmacological treatment with:
        1. ACE (angiotensin converting enzyme) inhibitors and angiotensin II receptor antagonists
        2. Antidepressants (SNRIs, SSRIs, tricyclics)
        3. Centrally acting alpha-adrenergic-receptor agonists
        4. Beta blockers
        5. Calcium channel blockers
        6. Antiepileptics
        7. Other serotonergic modulators
        8. NMDA receptor antagonists
  5. Drafting recommendations - Part 2 only (Closed session)
  6. ADHD update – Introduction to the topicPart 2 only (closed session)
  7. Reflections on the day and AOB Part 2 only (closed session)

Close of meeting

Final Agenda – Tuesday 23 June 2015

The meeting will start promptly at 10.10 and is expected to finish at approximately 17.00

  1. Welcome and introductions - Part 1 only (open session)
  2. Code of Conduct for members of the public attending the meeting - Part 1 only (open session)
  3. Declarations of Interest – Part 1 only (open session)
  4. Objectives of the day - Part 1 only (open session)
  5. Topic: VTE Management update - Part 1 only (open session)
    1. Review question: What is the effectiveness of thrombolysis given in addition to standard accepted anticoagulation therapy compared with anticoagulation therapy alone in patients with confirmed pulmonary embolism and haemodynamic stability who present with right ventricular dysfunction?
  6. Draft recommendations – Part 2 only (closed session)
  7. LUNCH
  8. Topic: VTE Management update - Part 1 only (open session)
    1. Review question: What is the effectiveness of stockings to prevent post-thrombotic syndrome (PTS) in people with confirmed proximal DVT?
  9. Draft recommendations – Part 2 only (closed session)
  10. Reflections on the day and AOB – Part 2 only (closed session)

Close of meeting

Please note all timings are approximate.

Date, time and venue of next meeting

24 & 25 September 2015 10:00, NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester, M1 4BT

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is 08 June 2015. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Lee Berry


Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email Nice@nice.org.uk further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

 

Registration period: 22 May 2015 to 08 June 2015
Registration is closed.